These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26752277)

  • 1. Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy.
    Schouten J; Su T; Wit FW; Kootstra NA; Caan MW; Geurtsen GJ; Schmand BA; Stolte IG; Prins M; Majoie CB; Portegies P; Reiss P;
    AIDS; 2016 Apr; 30(7):1027-38. PubMed ID: 26752277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection.
    Su T; Schouten J; Geurtsen GJ; Wit FW; Stolte IG; Prins M; Portegies P; Caan MW; Reiss P; Majoie CB; Schmand BA;
    AIDS; 2015 Mar; 29(5):547-57. PubMed ID: 25587908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on combination antiretroviral therapy.
    Su T; Wit FW; Caan MW; Schouten J; Prins M; Geurtsen GJ; Cole JH; Sharp DJ; Richard E; Reneman L; Portegies P; Reiss P; Majoie CB;
    AIDS; 2016 Sep; 30(15):2329-39. PubMed ID: 27149087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment and cardiovascular disease related to alexithymia in a well-controlled HIV-infected population.
    Ciccarelli N; Baldonero E; Milanini B; Fabbiani M; Cauda R; Di Giambenedetto S; Silveri MC
    Infez Med; 2019 Sep; 27(3):274-282. PubMed ID: 31545771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia.
    Ciccarelli N; Fabbiani M; Colafigli M; Trecarichi EM; Silveri MC; Cauda R; Murri R; De Luca A; Di Giambenedetto S
    Antivir Ther; 2013; 18(2):153-60. PubMed ID: 23486721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral blood flow and cognitive function in HIV-infected men with sustained suppressed viremia on combination antiretroviral therapy.
    Su T; Mutsaerts HJ; Caan MW; Wit FW; Schouten J; Geurtsen GJ; Sharp DJ; Prins M; Richard E; Portegies P; Reiss P; Majoie CB;
    AIDS; 2017 Mar; 31(6):847-856. PubMed ID: 28121708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.
    Sacktor N; Nakasujja N; Skolasky R; Robertson K; Wong M; Musisi S; Ronald A; Katabira E
    Neurology; 2006 Jul; 67(2):311-4. PubMed ID: 16864825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of glycemic status on longitudinal cognitive performance in men with and without HIV infection.
    Yang J; Jacobson LP; Becker JT; Levine A; Martin EM; Munro CA; Palella FJ; Lake JE; Sacktor NC; Brown TT
    AIDS; 2018 Aug; 32(13):1849-1860. PubMed ID: 29746300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients.
    Fabbiani M; Ciccarelli N; Tana M; Farina S; Baldonero E; Di Cristo V; Colafigli M; Tamburrini E; Cauda R; Silveri MC; Grima P; Di Giambenedetto S
    HIV Med; 2013 Mar; 14(3):136-44. PubMed ID: 22994586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.
    Rajasuriar R; Booth D; Solomon A; Chua K; Spelman T; Gouillou M; Schlub TE; Davenport M; Crowe S; Elliott J; Hoy J; Fairley C; Stewart G; Cameron P; Lewin SR
    J Infect Dis; 2010 Oct; 202(8):1254-64. PubMed ID: 20812848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premature age-related comorbidities among HIV-infected persons compared with the general population.
    Guaraldi G; Orlando G; Zona S; Menozzi M; Carli F; Garlassi E; Berti A; Rossi E; Roverato A; Palella F
    Clin Infect Dis; 2011 Dec; 53(11):1120-6. PubMed ID: 21998278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment.
    Capeau J; Bouteloup V; Katlama C; Bastard JP; Guiyedi V; Salmon-Ceron D; Protopopescu C; Leport C; Raffi F; Chêne G;
    AIDS; 2012 Jan; 26(3):303-14. PubMed ID: 22089377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-sectional analysis of cognitive function using multivariate normative comparisons in men with HIV disease.
    Wang Z; Molsberry SA; Cheng Y; Kingsley L; Levine AJ; Martin E; Munro CA; Ragin A; Rubin LH; Sacktor N; Seaberg EC; Becker JT;
    AIDS; 2019 Nov; 33(14):2115-2124. PubMed ID: 31335803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients.
    Ciccarelli N; Grima P; Fabbiani M; Baldonero E; Borghetti A; Milanini B; Limiti S; Colafigli M; Tamburrini E; Cauda R; De Luca A; Di Giambenedetto S
    Antivir Ther; 2015; 20(4):433-40. PubMed ID: 25504667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral vasoreactivity is impaired in treated, virally suppressed HIV-infected individuals.
    Chow FC; Boscardin WJ; Mills C; Ko N; Carroll C; Price RW; Deeks S; Sorond FA; Hsue PY
    AIDS; 2016 Jan; 30(1):45-55. PubMed ID: 26372478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive functioning, wellbeing and brain correlates in HIV-1 infected patients on long-term combination antiretroviral therapy.
    Janssen MA; Meulenbroek O; Steens SC; Góraj B; Bosch M; Koopmans PP; Kessels RP
    AIDS; 2015 Oct; 29(16):2139-48. PubMed ID: 26544578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV, Depression, and Cognitive Impairment in the Era of Effective Antiretroviral Therapy.
    Rubin LH; Maki PM
    Curr HIV/AIDS Rep; 2019 Feb; 16(1):82-95. PubMed ID: 30661180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
    Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
    AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of HIV and combination antiretroviral therapy on cortico-striatal functional connectivity.
    Ortega M; Brier MR; Ances BM
    AIDS; 2015 Mar; 29(6):703-12. PubMed ID: 25849834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.